August 2026 cannabis M&A landed with force. Seven confirmed deals broke across June and July, with Vireo Growth announcing back to back transactions that will reshape the national dispensary count, SNDL completing a secured creditor foreclosure that makes it the largest cannabis retailer by store count, and Red White & Bloom walking away from Florida entirely. The wave of August 2026 cannabis M&A activity is concentrated in distressed and consolidation driven plays, with Cannabist’s bankruptcy providing the inventory and aggressive acquirers doing the buying.
🔥 MARKET SIGNALS THIS MONTH:
- Vireo Growth advances three overlapping acquisitions, projecting toward 265 dispensaries across 15 states on a pro forma basis once all pending deals close, which would make it the largest U.S. cannabis company by store count
- Cluster of distressed or forced exits in Florida: SNDL forecloses on Surterra, RWB divests all FL operations, both closing in July 2026
- SNDL becomes one of the first Nasdaq-listed companies with indirect, and eventually direct, consolidated exposure to U.S. medical cannabis via secured creditor foreclosure, a novel exit structure for the sector
Top Headlines
- 🔥 Vireo acquires Planet 13 in all-stock deal
- 🔥 SNDL forecloses on Surterra, becomes largest cannabis retailer by store count
- 🔥 RWB divests all Florida operations, eliminates $123M in liabilities
- Vireo buys Cannabist assets across five states for $35M
- FLUENT sells New York license, Etain operations
- TerrAscend agrees to acquire Aunt Mary’s Dispensary for $9M
- Klutch Cannabis acquires Columbus dispensary, enters central Ohio
Deal Tracker: By Geographic Region
Multi-Region
Colorado / Illinois / Massachusetts / New Jersey / West Virginia: Acquisition
Vireo Growth entered a definitive purchase agreement to acquire cannabis cultivation, manufacturing, and retail operations from Cannabist subsidiaries across Colorado, Illinois, Massachusetts, New Jersey, and West Virginia for up to $35 million ($18.75 million cash at closing, $16.25 million in seller notes). The deal adds up to 25 dispensaries, one cultivation facility, and one production facility across five states.
Cannabist’s New Jersey cultivation sites in Vineland closing separately as 86 workers are laid off and lender East West Bank holds $15.9 million in outstanding debt on those facilities.
Nevada / Florida / Illinois: 🔥 Merger
Vireo Growth Inc. entered into a definitive all-stock merger agreement on July 27, 2026, to acquire Planet 13 Holdings Inc. at an exchange ratio of 0.015383618 Vireo subordinate voting shares per Planet 13 share, representing a 16.6% premium over Planet 13’s 20-day volume-weighted average price and a 24% premium to the July 24 closing price. The deal adds 36 dispensaries across Nevada (two locations, including the Las Vegas flagship superstore), Florida cannabis M&A (approximately 33 dispensaries), and Illinois (Waukegan), plus three cultivation and production assets and up to 2.3 million square feet of expandable cultivation capacity in Nevada.
Upon completion of all pending acquisitions, Vireo expects to operate approximately 265 dispensaries across 15 states, which would position it as the largest U.S. cannabis company by store count. Vireo currently operates approximately 170 dispensaries across 10 states.
Northeast
New York: Divestiture
FLUENT Corp. agreed on July 22, 2026, to sell Etain LLC, its New York cannabis operations entity and Registered Organization license, to an unnamed third-party buyer for undisclosed cash consideration. The sale is tied to FLUENT’s ongoing plan of arrangement with Vireo Growth and requires New York State Cannabis Control Board approval.
Because Etain is FLUENT’s New York licensed entity, Vireo will not retain New York plant-touching operations through the FLUENT acquisition.
New Jersey: Acquisition
TerrAscend Corp. signed an agreement on June 30, 2026, to acquire Aunt Mary’s Dispensary in Flemington, Hunterdon County, for $9 million ($3 million five-year unsecured convertible promissory note plus $6 million cash upon option exercise). Aunt Mary’s generates over $10 million in annualized revenue and would become TerrAscend’s fifth New Jersey location.
Margin improvement expected through introduction of Kind Tree, Legend, Valhalla, and Cookies brands.
Southeast
🔥 Florida: Foreclosure acquisition
SNDL Inc. closed its acquisition of assets from Surterra Holdings (Parallel) on July 27, 2026, through a secured creditor foreclosure, adding 43 Surterra Wellness dispensaries in Florida, 10 Goodblend retail or pickup locations in Texas operating under the state’s Compassionate Use Program, and three NETA locations in Massachusetts, plus three cultivation and manufacturing facilities generating approximately $150 million in annualized revenue. The transaction extinguished approximately $842 million of Parallel’s debt.
SNDL now reports 249 retail cannabis stores globally, surpassing High Tide’s 229 to claim the title of largest cannabis retailer by store count. Note that SNDL currently holds the U.S. locations through indirect exposure rather than direct ownership.
🔥 Florida: Divestiture
Red White & Bloom Brands closed its divestiture of all majority equity interests in RWB Florida to M&V Investment One LLC and affiliates on July 14, 2026, with regulatory approval from the Office of Medical Marijuana Use. The transaction eliminates approximately $123.2 million in liabilities, removes $10 million in annual interest expense, and records an estimated $47.7 million non-cash gain.
RWB states it will now focus on organic growth, brand licensing, and acquiring scaled businesses in other markets. Figures are in Canadian dollars and remain estimates pending Q2 2026 financials.
Midwest
Ohio: Acquisition
Klutch Cannabis, a Northeast Ohio cannabis acquisition based vertically integrated company, acquired a Columbus dispensary license from Farkas Farms, marking its entry into the central Ohio market, while simultaneously selling its Loudonville dispensary to Farkas Farms.
No purchase price was disclosed.
Mountain West
No reported M&A activity this month.
West Coast
No reported M&A activity this month.
Deal Spotlight
Vireo Growth’s Three-Transaction Blitz
Vireo Growth has announced or closed three overlapping transactions: the $35 million Cannabist five-state acquisition (up to 25 dispensaries across Colorado, Illinois, Massachusetts, New Jersey, and West Virginia), the all-stock Planet 13 merger (36 dispensaries in Nevada, Florida, and Illinois), and the pending acquisition of FLUENT through a previously announced plan of arrangement (35 retail locations concentrated in Florida, plus Texas operations and a New York wholesale business). Stacked together, these deals push Vireo toward a pro forma count of approximately 265 dispensaries across 15 states, which would make it the largest U.S. cannabis company by store count. The strategic logic is consolidation at distressed pricing. Cannabist assets came out of Chapter 15 proceedings in Delaware recognizing a Canadian CCAA restructuring, at $35 million for up to 25 dispensaries, and the Planet 13 deal is an all-stock transaction at a modest 16.6% premium to VWAP. Vireo is not paying premium multiples. It is acquiring undervalued assets with existing customer bases at a moment when distressed sellers have limited negotiating power. The downstream risk is integration. Three overlapping acquisitions across nine states, each requiring separate regulatory approvals, creates operational complexity that can stress thin margins.
Trend Watch
Florida distressed exit cluster. Two separate forced exits in Florida closed or announced in July 2026: SNDL’s foreclosure of Surterra (43 dispensaries) and RWB’s divestiture of all Florida operations. Combined, these represent more than 40 retail locations changing hands or ownership structure in a single month. Florida’s vertically integrated license structure appears to be too capital intensive for overleveraged MSOs.
Cannabist bankruptcy continues supplying deal inventory. Vireo’s $35 million five-state purchase and the pending Denver facility closure (50 workers, effective September 11) confirm Cannabist’s breakup is ongoing. Cannabist has now divested or agreed to divest Virginia ($130 million), Ohio ($47 million), Delaware ($16.5 million), and a five-state portfolio ($35 million). The total disclosed divestiture value is approximately $228.5 million against $270 million-plus in debt, a figure that includes disputed IRS Section 280E claims.
SNDL’s Canadian capital structure enters U.S. retail via foreclosure. SNDL’s foreclosure acquisition positions it among the first Nasdaq-listed companies pursuing direct consolidated U.S. medical cannabis exposure, currently held indirectly. The structure (indirect 66.7% equity and 69.4% debt exposure via Sunstream Bancorp) is novel. SNDL expects to convert to direct consolidated holdings pending Nasdaq and regulatory approval.
All-stock deals signal buyer capital constraints. Vireo’s Planet 13 acquisition is all stock. FLUENT’s acquisition by Vireo was all stock. When buyers use equity rather than cash, it signals balance sheet limitations but also seller acceptance that cash is not available at this pricing level. Expect more stock for stock structures in August 2026 cannabis M&A going forward as the sector works through its capital shortage.
NJ dispensary consolidation continuing. TerrAscend acquiring Aunt Mary’s (fifth NJ location) plus Vireo absorbing three Cannabist NJ retailers point to a market where independent single-location dispensaries are increasingly attractive acquisition targets for MSOs seeking retail density.
Valuation Snapshot
Two deals this month carry disclosed fixed cash purchase prices with named buyers and sellers.
| Deal | State | Value | Type |
|---|---|---|---|
| Vireo / Cannabist | Multi-state | $35M | Acquisition |
| TerrAscend / Aunt Mary’s | New Jersey | $9M | Acquisition |
Mean of two disclosed deals: $22 million. Note: this mean is calculated across only two transactions (Vireo/Cannabist and TerrAscend/Aunt Mary’s) and should not be used as a sector benchmark. The Vireo/Cannabist deal is a multi-state bankruptcy acquisition; the TerrAscend deal is a single-store option structure. They are not comparable on a per unit or per revenue basis.
For context from prior reporting: Cannabist’s earlier bankruptcy divestitures were signed in March 2026 at $47 million for Ohio operations and $16.5 million for Delaware, with the Delaware sale expected to close in Q2 2026 and the Ohio sale in Q3 2026. The Vireo/Cannabist five-state package at $35 million implies roughly $1.4 million per dispensary at the full count of 25, though both the price and the store count are stated as maximums and the consideration also covers one cultivation and one production facility. That range remains broadly consistent with the distressed-sale pricing floor established in Q1.
The SNDL/Surterra and RWB/Florida transactions did not carry conventional purchase prices. SNDL’s deal extinguished approximately $842 million in Parallel debt through foreclosure. RWB eliminated $123.2 million in liabilities with a $47.7 million non-cash gain recorded. These are restructuring driven transactions, not market-rate acquisitions, and are excluded from the valuation aggregate. The Vireo/Planet 13 merger (all stock, no disclosed dollar value), the FLUENT/Etain sale (undisclosed cash consideration), and the Klutch/Columbus acquisition (purchase price not disclosed) are also excluded from the valuation aggregate for the same reason.
National Cannabis Acquisition Opportunities
High-Value Cannabis Acquisitions Now Available
CannDev is offering turnkey cannabis dispensaries and vertical license platforms across high-barrier markets. The properties below represent our current inventory of cash flowing operations and expansion ready licenses available for immediate acquisition.
Chicago, IL
Asking: $3,500,000
- Operating dispensary generating approximately $2.9M in gross revenue in 2025 with roughly $1M in gross profit
- Current rent of $30,000/mo, with room to renegotiate down to $20,000 to $25,000/mo
- Drive-thru infrastructure ready and just approved by the state
- Located in a former bank building on a major street
Brooklyn, NY (Park Slope, 4th Ave)
Asking: $3,000,000
- Open just over 12 months, generating $2.6M in gross revenue with increasing month over month sales
- $850K in net profit over the last 12 months
- 2,000 SF space on a 10+ year lease at $25,750/mo with 25,000 daily traffic count
- Strong unit economics with revenue and profitability trajectory heading in the right direction
Albany, NY (Downtown)
Asking: $2,400,000
- Open and operating, 11 months in business with run rate revenue of $115K/mo and growing
- Brand new Class A 1,700 SF buildout with an 11-car lot and drive-thru infrastructure ready to activate
- No other dispensaries within half a mile, only 3 within a mile with significant market whitespace
- 46% gross margin, ~$160K net income across operating period with material EBITDA upside post-close
- Absentee owned, 14-year NNN lease at $5,300/mo with strong upside for an owner-operator
Florida (Vertical MMTC Platform, Statewide)
Asking: $4,000,000
- Vertical Florida MMTC license with unlimited cultivation capacity and unlimited dispensary openings statewide, all state authorizations already received
- Turnkey light deprivation greenhouse: 20,000 SF of operating cultivation on 70+ acres of zoned Ag land with significant expansion runway and no building permits required
- Four operating retail dispensaries across four distinct regional markets, available via lease transfer for an immediate statewide footprint from day one
- Asset-light structure with approximately $950K in aggregate annual rent across all five leases, with retail terms running through 2032 to 2038
- Florida on pace to surpass $2B in statewide medical sales in 2026, with only 40 MMTC licenses issued in a state of 23M+ residents – one of the most defensible license positions in the US
- NDA required for full CIM, asset addresses, lease abstracts, and data room access
Camden, NJ (Licensed Dispensary)
Asking: $400,000
- Fully licensed dispensary generating $1.5M in 2025 revenue
- 2,500 SF space at $5,625/mo with lease transfer included in the purchase
- Purchase includes the license and full lease assignment, turnkey acquisition
- One of the most competitively priced cash flowing dispensaries currently on the market
Interested in any of these opportunities? Contact us to discuss further.
The Bottom Line
Seven deals across June and July 2026, and the pattern is clear: distressed inventory is driving August 2026 cannabis M&A, and Vireo Growth is the most aggressive acquirer in the market right now. Florida produced two significant forced exits in a single month, which signals that vertically integrated license structures with high capital costs are under severe stress in that state. The buyer universe has narrowed; most active acquirers are MSOs using stock or seller notes rather than cash, which means sellers accepting these deals are prioritizing exit over price.
Watch New York as a regulatory bottleneck rather than an expansion target. The Cannabis Control Board’s decision on the Etain license transfer is a gating item for Vireo’s FLUENT arrangement, and Vireo will exit New York plant-touching operations as a result. Any seller in a limited-license state with meaningful EBITDA and clean compliance records is in a favorable position right now, because the pool of motivated buyers with scale is actively hunting. If you are evaluating exit timing, this consolidation window may not last past 2026.
📬 Track Cannabis M&A Every Month
Get monthly cannabis M&A deal flow, valuation data, and market signals delivered to your inbox. Built for investors and executives evaluating acquisition timing.
